Haemophilia patients launch action against Bayer over contaminated blood productsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7402.1286-g (Published 12 June 2003) Cite this as: BMJ 2003;326:1286
- Deborah Josefson
A class action lawsuit has been launched against the Bayer and Baxter corporations on behalf of people with haemophilia in Asia and Latin America who contracted HIV or hepatitis through contaminated blood products supplied by the companies.
Also named in the lawsuit were the Armour Pharmaceutical Company and Alpha Therapeutic Corporation. The suit was filed in a US federal court in California.
All four companies are accused of distributing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial